So, despite the current freak out on Wall Street, things aren't all bad for start-ups. That is, unless you're trying to go public. Fluidigm, the VC-backed tech start-up that had intended to go public two weeks ago, announced late last week that they're withdrawing their IPO.

While the news isn't terrible surprising—who goes public in the midst of a historically insane week on Wall Street?—it would have been an interesting IPO to watch. That's because the biotech company has been bleeding cash. They reported a net loss of $25.5 million on $7.3 million in revenue in 2007 and predicts losses for the foreseeable future, reports the New York Times.

Regardless of Wall Street's tumult, would anyone have wanted to buy stock from a company like that anyhow?